Fundz

Glycomine, Inc. reported raising $4.93 Million in an initial SEC Form D filing, from an offering of $12.6 Million

PRIVATENov 14, 2016$4.9M of $12.6M raised

Amount Raised

$4.93 Million

$4.93 Million sold, per SEC Form D (first sale Nov 14, 2016)

Round Type

Seed

San FranciscoBiotechnology

Quick answer

Glycomine, Inc. raised $4.93 Million in a Seed round, dated November 14, 2016. Glycomine, Inc. is based in San Francisco, California, United States.

How much did Glycomine, Inc. raise?
Glycomine, Inc. raised $4.93 Million in a Seed round on November 14, 2016.
What does Glycomine, Inc. do?
Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.
Where is Glycomine, Inc. based and how big is it?
Glycomine, Inc. is based in San Francisco, California, United States.
Who are the decision-makers at Glycomine, Inc?
Fundz holds 1 contact at Glycomine, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Glycomine, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Aurora Biopharma, Inc. raised $340K (Seed) on December 29, 2016.
  • Capio Biosciences, Inc. raised $2.9M (Seed) on December 29, 2016.
  • Satsuma Pharmaceuticals, Inc. raised $6M on December 29, 2016.
  • BIO-NEMS Corp raised $182K (Seed) on December 29, 2016.
  • Aurora Biopharma, Inc. raised $100K (Pre-Seed) on December 29, 2016.
  • Co-Diagnostics, Inc. raised $750K (Seed) on December 29, 2016.

Who to call at Glycomine, Inc., and when

A new round usually means Glycomine, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Glycomine, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Glycomine, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Glycomine, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Glycomine, Inc.

Location

953 INDIANA STREET

San Francisco, California, United States

About

Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist. The company's approach is to use replacement therapies – substrates, enzymes, or proteins – and to target those molecules to clinically relevant cellular compartments. The company is based in San Carlos, California and supported by leading international life sciences investors. For more info, visit www.glycomine.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Glycomine, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts4 people are listed at Glycomine, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Glycomine, Inc.'s next move

See what Strategic adds

Glycomine, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.